These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10830108)

  • 21. New light on an old story: von Willebrand factor binding to collagen.
    Chen J; López JA
    J Thromb Haemost; 2006 Oct; 4(10):2148-50. PubMed ID: 16999849
    [No Abstract]   [Full Text] [Related]  

  • 22. Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.
    Schneppenheim R; Brassard J; Krey S; Budde U; Kunicki TJ; Holmberg L; Ware J; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3581-6. PubMed ID: 8622978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired abnormalities of von Willebrand factor: facts to consider in patients with unexpected bleeding.
    Ruggeri ZM
    J Lab Clin Med; 1993 Mar; 121(3):377-9. PubMed ID: 8445284
    [No Abstract]   [Full Text] [Related]  

  • 24. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
    Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
    Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
    Keeney S; Cumming A; Hay C
    Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor.
    Millar CM; Riddel AF; Griffioe A; Jenkin PV; Brown SA
    Br J Haematol; 2005 Aug; 130(3):462-3. PubMed ID: 16042701
    [No Abstract]   [Full Text] [Related]  

  • 29. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
    Castaman G; Giacomelli S; Rodeghiero F
    Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical approach to genetic testing for von Willebrand disease.
    Pruthi RK
    Mayo Clin Proc; 2006 May; 81(5):679-91. PubMed ID: 16706266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of type 2B von Willebrand disease reverse to normal when treated with high doses of protease inhibitor.
    Arkel YS; Ku DH; Lake C; Pasquale L; Lam X; Gibson D; Burstin S
    Thromb Haemost; 1999 Nov; 82(5):1558-9. PubMed ID: 10595658
    [No Abstract]   [Full Text] [Related]  

  • 33. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions.
    Perkins SJ; Smith KF; Williams SC; Haris PI; Chapman D; Sim RB
    J Mol Biol; 1994 Apr; 238(1):104-19. PubMed ID: 8145250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
    Lanke E; Kristoffersson AC; Philips M; Holmberg L; Lethagen S
    Thromb Haemost; 2008 Aug; 100(2):211-6. PubMed ID: 18690339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):111-8. PubMed ID: 19506357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor B structure provides insights into activation of the central protease of the complement system.
    Milder FJ; Gomes L; Schouten A; Janssen BJ; Huizinga EG; Romijn RA; Hemrika W; Roos A; Daha MR; Gros P
    Nat Struct Mol Biol; 2007 Mar; 14(3):224-8. PubMed ID: 17310251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
    Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C
    Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet von Willebrand factor in inherited and acquired bleeding disorders.
    Mannucci PM
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2428-32. PubMed ID: 7708659
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.
    Nitu-Whalley IC; Riddell A; Lee CA; Pasi KJ; Owens D; Enayat MS; Perkins SJ; Jenkins PV
    Thromb Haemost; 2000 Dec; 84(6):998-1004. PubMed ID: 11154147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.